pfizer, so there's some flexibility to do that. and i think that's where individual conversation needs to take place. but johnson & johnson, you need to get something. the efficacy rates were not high enough to feel like you can be protected months out. >> last question here, real quick. remember when johnson & johnson was first released, it was then subsequently paused for about ten days because this very rare side effect of blood clotting in individuals. is this currently a risk for people getting a second booster of johnson & johnson, yes, rare, but still a risk? >> it's rare. it was not seen in the boosted data population. i would say that's exactly the reason why i would say you should talk to your physician if you're a woman under the age of 50 and you are at higher risk and didn't experience anything with your j&j vaccine, it's worth having that conversation. so, i'm glad you pointed that out. but no, they did not see any risks, so there's no increased risk, and it is incredibly rare, but you know, honestly, when in doubt, have that conversation.